Bioquell, Inc.

One of Europe's leading burns units has significantly reduced the incidence of noscomial MRSA and Acinetobacter baumannii using a bundle of infection control measures using the latest hydrogen peroxide vapor (HPV) disinfection technology.

In the United States, the CDC estimates the cost of healthcare associated infections (HAIs) range upward of $40 billion dollars annually. To help in the fight against HAIs, Bioquell has launched its educational Bug Stoppers campaign.

The latest generation hydrogen peroxide bio-decontamination technology from Bioquell has now achieved Australian C-Tick approval. Targeted at the life sciences and healthcare markets, this unique methodology is used to eradicate microbes.

Innovative bio-decontamination technology now interfaces with market leading data logging system to provide robust and secure information capture for the life science and pharmaceutical markets.

Bioquell has developed a comprehensive and freely available online ‘bug’ database. The micro site features over 30 of the most common environmental contaminants and provides valuable insight into the world of bacteria, viruses, and fungi.

Superbugs are becoming more resistant to the current portfolio of antibiotics. Minimizing the risk of pathogen transfer from healthcare surroundings to the patient needs to be a key focus to help prevent unwanted infections.

Hydrogen peroxide bio-decontamination technology is one of the hot topics at this year’s 49th Annual Meeting of the Infectious Diseases Society of America and the HIV Medicine Association in Boston, Massachusetts on October 20-23, 2011.